RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RUGGENENTI P
Collezione ASL Città di Torino

Items : 4

Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2024 Sep 10;15:1460317. doi: 10.3389/fimmu.2024.1460317. eCollection 2024.

2024
ASL Città di Torino

Carrara C; Mataj B; Gastoldi S; Ruggenenti P; Sciascia S; Roccatello D;

Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification. in Mayo Clinic proceedings / Mayo Clin Proc. 2023 Nov;98(11):1671-1684. doi: 10.1016/j.mayocp.2023.08.006. Epub 2023 Oct 5.

2023
ASL Città di Torino

Sethi S; Beck LH Jr; Glassock RJ; Haas M; De Vriese AS; Caza TN; Hoxha E; Lambeau G; Tomas NM; Madden B; Debiec H; D'Agati VD; Alexander MP; Amer H; Appel GB; Barbour SJ; Caravaca-Fontan F; Cattran DC; Casal Moura M; D'Avila DO; Eick RG; Garovic VD; Greene EL; Herrera Hernandez LP; Jennette JC; Lieske JC; Markowitz GS; Nath KA; Nasr SH; et alii...

Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. in Kidney international / Kidney Int. 2023 Dec;104(6):1092-1102. doi: 10.1016/j.kint.2023.06.032. Epub 2023 Oct 5.

2023
ASL Città di Torino

A multidrug, antiproteinuric approach to alport syndrome: a ten-year cohort study. in Nephron / Nephron. 2015;130(1):13-20. doi: 10.1159/000381480. Epub 2015 Apr 21.

2015
ASL Città di Torino

Daina E; Cravedi P; Alpa M; Roccatello D; Gamba S; Perna A; Gaspari F; Remuzzi G; Ruggenenti P;